Karolinska Development AB ( (SE:KDEV)) has provided an update. Karolinska Development’s portfolio company SVF Vaccines has signed a non-binding letter of intent for a reverse takeover of Novakand ...

Karolinska Development (STO:KDEV) has stopped investing in three of its portfolio biotechs and fully written off its outlay in the businesses to date. The decisions contributed to the valuation of the ...

This article is intended for those of you who are at the beginning of your investing journey and want to better understand how you can grow your money by investing in Karolinska Development AB (publ) ...

Karolinska Development (STO:KDEV) has slashed the value of its portfolio after adopting a new way of tallying up what its early-stage biotech investments are worth. The new accounting model and the ...

STOCKHOLM, SWEDEN – February 28, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that the number of shares and votes has changed during February 2022 as a result of the rights ...

If the original Linux-based FoxBox SMS didn't boast quite the capabilities you were looking for, then perhaps KDev's upgraded FoxBox MMS will be more to your liking. Like the original FoxBox, it'll ...

Karolinska Development AB ( (SE:KDEV)) has issued an announcement. Karolinska Development’s portfolio company, SVF Vaccines, has presented promising preclinical data on its immunotherapy, SVF-001, ...

Karolinska Development [KDEV], developer of life science innovations that meet tomorrow's medical need, will visit the NASDAQ MarketSite in Times Square. In honor of the occasion, Torbjörn Bjerke, CEO ...

As of 1:06:04 pm GMT+1. Market open.

New firm will include existing portfolio company Akinion and four to five new project businesses. Swedish life science investor and incubator organization Karolinska Development has established a new ...

As of 4:50:23 pm GMT+1. Market open.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.